OPEN APP
Home >Companies >Company Results >Natco Pharma Q3 result: Net profit declines 39% to 63 crore
Photo: Ramesh Pathania/Mint
Photo: Ramesh Pathania/Mint

Natco Pharma Q3 result: Net profit declines 39% to 63 crore

The consolidated total income of the company stood at 386 crore for the quarter under consideration. It was 513 crore for the same period a year ago

NEW DELHI : Drug firm Natco Pharma on Thursday reported a 39.27% decline in its consolidated net profit to 63.4 crore for the quarter ended in December.

The company had posted a net profit of 104.4 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.

The consolidated total income of the company stood at 386 crore for the quarter under consideration. It was 513 crore for the same period a year ago, it added.

The decline in revenue and profits was due to lower domestic oncology sales and weak realisation of profits from oseltamivir products in the US, Natco Pharma said.

The board of directors has recommended a third interim dividend of Re 1 per equity share of 2 each, it added.

Shares of Natco Pharma closed at 884.55 on the BSE, down 0.22% from its previous close.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Close
×
Edit Profile
My ReadsRedeem a Gift CardLogout